IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

EU fines six pharma firms for curbing entry of cheaper generic drugs

5:26 AM MDT | July 10, 2014 | Natasha Alperowicz

The European Commission announced on Wednesday that it has imposed fines totaling €427.7 million ($582.8 million) on the French pharmaceutical company Servier and five producers of generic drugs—Niche/Unichem; Matrix, now part of Mylan; Teva; Krka; and Lupin—for concluding a series of deals to protect Servier's best-selling blood pressure medicine, perindopril, from price competition by generics in the European Union. Through a technology acquisition and a series of patent settlements with generic rivals, Servier breached EU antitrust rules by...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa